Vernakalant
Back to searchMolecule Structure
Scientific Name
Vernakalant
Description of the Drug
Vernakalant is an antiarrhythmic medication used to treat patients with atrial fibrillation.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB06217
http://www.drugbank.ca/drugs/DB06217
Brand Name(s)
Not Available
Company Owner(s)
Not Available
Mechanism(s) Of Action
| Target Name | Target Type | Action Type | Target ChEMBL ID |
|---|---|---|---|
| Kir3.1/Kir3.4 | PROTEIN COMPLEX | BLOCKER | CHEMBL3038488 |
| Voltage-gated potassium channel subunit Kv4.3 | SINGLE PROTEIN | BLOCKER | CHEMBL1964 |
| HERG | SINGLE PROTEIN | BLOCKER | CHEMBL240 |
| Sodium channel protein type V alpha subunit | SINGLE PROTEIN | BLOCKER | CHEMBL1980 |
| Voltage-gated potassium channel subunit Kv1.5 | SINGLE PROTEIN | BLOCKER | CHEMBL4306 |
Clinical Trial(s)
Unichem Links
| SureChEMBL | SCHEMBL410062 |
| DrugBank | DB06217 |
| PubChem: Thomson Pharma | 16881656 |
| PubChem | 9930049 |
| LINCS | LSM-45707 |
| Nikkaji | J2.804.733I |
| EPA CompTox Dashboard | DTXSID60229659 |
| DrugCentral | 4365 |
| ChemicalBook | CB02498847 |
| ChEBI | 135956 |
| ZINC | ZINC000022010910 |
